BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2237824)

  • 1. Ability of high-affinity heparin fractions with decreasing affinity for antithrombin III to activate ATIII isoforms.
    Carlson TH; Kolman MR; Frees A; Babcock T
    Thromb Res; 1990 Aug; 59(3):521-30. PubMed ID: 2237824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of sulfation on the anticoagulant and antithrombin III-binding properties of a heparin fraction with low affinity for antithrombin III.
    Schoen P; Wielders S; Petitou M; Lindhout T
    Thromb Res; 1990 Feb; 57(3):415-23. PubMed ID: 2315894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the heparin-binding site of glia-derived nexin/protease nexin-1.
    Rovelli G; Stone SR; Guidolin A; Sommer J; Monard D
    Biochemistry; 1992 Apr; 31(13):3542-9. PubMed ID: 1554734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin surface immobilization through hydrophilic spacers: thrombin and antithrombin III binding kinetics.
    Byun Y; Jacobs HA; Kim SW
    J Biomater Sci Polym Ed; 1994; 6(1):1-13. PubMed ID: 7947469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interactions between antithrombin III, thrombin and surface immobilized heparin.
    van Delden CJ; Engbers GH; Feijen J
    J Biomater Sci Polym Ed; 1996; 7(11):989-1004. PubMed ID: 8858487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding kinetics of thrombin and antithrombin III with immobilized heparin using a spacer.
    Byun Y; Jacobs HA; Kim SW
    ASAIO J; 1992; 38(3):M649-53. PubMed ID: 1457941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of heparin fractions of different affinities to antithrombin III and thrombin on the inactivation of thrombin and factor Xa by antithrombin III.
    Cerskus AL; Birchall KJ; Ofosu FA; Hirsh J; Blajchman MA
    Can J Biochem Cell Biol; 1984 Oct; 62(10):975-83. PubMed ID: 6509363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of antithrombin III and thrombin to immobilized heparin under flow conditions.
    Byun Y; Jacobs HA; Kim SW
    Biotechnol Prog; 1996; 12(2):217-25. PubMed ID: 8857192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin binding domain peptides of antithrombin III: analysis by isothermal titration calorimetry and circular dichroism spectroscopy.
    Tyler-Cross R; Sobel M; Marques D; Harris RB
    Protein Sci; 1994 Apr; 3(4):620-7. PubMed ID: 8003980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of antithrombin III isoforms by heparan sulphate glycosaminoglycans and other sulphated polysaccharides.
    Carlson TH; Kolman MR; Piepkorn M
    Blood Coagul Fibrinolysis; 1995 Jul; 6(5):474-80. PubMed ID: 8589216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms responsible for catalysis of the inhibition of factor Xa or thrombin by antithrombin using a covalent antithrombin-heparin complex.
    Paredes N; Wang A; Berry LR; Smith LJ; Stafford AR; Weitz JI; Chan AK
    J Biol Chem; 2003 Jun; 278(26):23398-409. PubMed ID: 12695507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of heparin on the inhibition of the contact system enzymes.
    Colman RW; Scott CF; Pixley RA; de la Cadena RA
    Ann N Y Acad Sci; 1989; 556():95-103. PubMed ID: 2786690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial glycosylation of antithrombin III asparagine-135 is caused by the serine in the third position of its N-glycosylation consensus sequence and is responsible for production of the beta-antithrombin III isoform with enhanced heparin affinity.
    Picard V; Ersdal-Badju E; Bock SC
    Biochemistry; 1995 Jul; 34(26):8433-40. PubMed ID: 7599134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Energetics of hydrogen bond switch, residue burial and cavity analysis reveals molecular basis of improved heparin binding to antithrombin.
    Singh P; Singh K; Jairajpuri MA
    J Biomol Struct Dyn; 2011 Oct; 29(2):339-50. PubMed ID: 21875153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement of lysine residues outside of the proposed pentasaccharide binding region for high affinity heparin binding and activation of human antithrombin III.
    Kridel SJ; Chan WW; Knauer DJ
    J Biol Chem; 1996 Aug; 271(34):20935-41. PubMed ID: 8702852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic analysis of various heparin fractions and heparin substitutes in the thrombin inhibition reaction.
    Pletcher CH; Cunningham M; Nelsestuen GL
    Biochim Biophys Acta; 1985 Jan; 838(1):106-13. PubMed ID: 2578296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow and the inhibition of prothrombinase by antithrombin III and heparin.
    Schoen P; Lindhout T
    Blood; 1991 Jul; 78(1):118-24. PubMed ID: 2070046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of S-protein of complement with thrombin and antithrombin III during coagulation. Protection of thrombin by S-protein from antithrombin III inactivation.
    Podack ER; Dahlbäck B; Griffin JH
    J Biol Chem; 1986 Jun; 261(16):7387-92. PubMed ID: 3754869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of activated protein C and inactivation of cell-bound thrombin by antithrombin III at the surface of cultured vascular endothelial cells--a comparative study of two anticoagulant mechanisms.
    Delvos U; Meusel P; Preissner KT; Müller-Berghaus G
    Thromb Haemost; 1987 Feb; 57(1):87-91. PubMed ID: 3590084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the antithrombin III heparin binding site.
    Ersdal-Badju E; Lu A; Zuo Y; Picard V; Bock SC
    J Biol Chem; 1997 Aug; 272(31):19393-400. PubMed ID: 9235938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.